Corante

About this Author
Derek Lowe
Derek Lowe, an Arkansan by birth, got his BA from Hendrix College and his PhD in organic chemistry from Duke before spending time in Germany on a Humboldt Fellowship on his post-doc. He's worked for several major pharmaceutical companies since 1989 on drug discovery projects against schizophrenia, Alzheimer's, diabetes, osteoporosis and other diseases. To contact Derek email him directly: derekb.lowe@gmail.com Twitter: Dereklowe

Chemistry and Drug Data: Drugbank
Emolecules
ChemSpider
Chempedia Lab
Synthetic Pages
Organic Chemistry Portal
PubChem
Not Voodoo
DailyMed
Druglib
Clinicaltrials.gov

Chemistry and Pharma Blogs:
Org Prep Daily
The Haystack
MedChem Buzz
Kilomentor
On Pharma
A New Merck, Reviewed
Liberal Arts Chemistry
One in Ten Thousand
Electron Pusher
Periodic Tabloid
All Things Metathesis
C&E News Blog
Propter Doc
Chemiotics II
The Chemical Notebook
Chemical Space
Noel O'Blog
In Vivo Blog
Terra Sigilatta
Chirality
BBSRC/Douglas Kell
ChemBark
Drug Discovery Opinion
Realizations in Biostatistics
Chemjobber
Pharmalot
WSJ Health Blog
ChemSpider Blog
Pharmagossip
Med-Chemist
Organic Chem - Education & Industry
Useful Chemistry
Chiral Jones
Pharma Strategy Blog
No Name No Slogan
Practical Fragments
SimBioSys
The Curious Wavefunction
Natural Product Man
Totally Synthetic
Fragment Literature
The F- Blog
Chemistry World Blog
Synthetic Nature
Chemistry Blog
Synthesizing Ideas
Carbon-Based Curiosities
Experimental Error
Business|Bytes|Genes|Molecules
Eye on FDA
Sigma-Aldrich ChemBlogs
Chemical Forums
Depth-First
Symyx Blog
P212121
ChemCafe
Sceptical Chymist
Lamentations on Chemistry
Computational Organic Chemistry
Mining Drugs
Henry Rzepa


Science Blogs and News:
Bad Science
The Loom
Uncertain Principles
Fierce Biotech
Blogs for Industry
Omics! Omics!
Young Female Scientist
Notional Slurry
Nobel Intent
SciTech Daily
Science Blog
FuturePundit
Aetiology
Gene Expression (I)
Gene Expression (II)
Sciencebase
Pharyngula
Adventures in Ethics and Science
Transterrestrial Musings
Slashdot Science
A Scientist's Life
Speculist
Cosmic Variance
The Capsule
Zeroth Order Approximation
Biology News Net


Medical Blogs
Med Tech Sentinel
DB's Medical Rants
Science-Based Medicine
GruntDoc
The Health Care Blog
Respectful Insolence
Black Triangle
Diabetes Mine


Economics and Business
Marginal Revolution
Arnold Kling
The Volokh Conspiracy
Knowledge Problem
The Stalwart


Politics / Current Events
Virginia Postrel
Tinkerty Tonk
Instapundit
Megan McArdle
Mickey Kaus
Colby Cosh
Alien Corn
No Watermelons


Belles Lettres
Two Blowhards
Critical Mass
Arts and Letters Daily
God of the Machine
Armavirumque
About Last Night
In the Pipeline: Don't miss Derek Lowe's excellent commentary on drug discovery and the pharma industry in general at In the Pipeline

In the Pipeline

« Stem Cell Politics | Main | Beta-Amyloid: An Antibiotic? »

March 16, 2010

Terra Incognita

Email This Entry

Posted by Derek

I was thinking the other day about the sheer number of reasonable chemical structures that have never been made. Chemical space is famously roomy - that's how we make a living in the drug industry, since we prefer to make things that have never been made before. And it still surprises non-chemists when I tell them that I make new compounds all the time - the feeling, I think, is that anything that's reasonably easy to make surely must have been mined out long ago. Not so. (It's worth remembering, though, that just because something's never been reported doesn't always mean that you can't buy it).

What brought this to mind was a steroid structure that I saw during a presentation. Looking at it like a medicinal chemist, I wondered idly if the carbons in the famous steroid backbone had ever been swapped out much with oxygen or nitrogen atoms. And in a few cases they have (more for oxygen, in some natural products), but for the most part, no. You can drop a tertiary amine into some spots on the steroid framework and immediately come up with no literature hits whatsoever. Many others yield only a handful.

It's worth noting that the partially-aromatized steroids have had some of this kind of work done on them - for example here and here. The aromatic rings give you a bit more of a handle to work with, but even here it's not like the literature is always packed with examples.

So there's as bioactive a scaffold as you could ask for, but many of the simple analogs still haven't been described. To be fair, these azasteroids aren't simple to make, and probably wouldn't have steroid-like activities in many cases. (Their natural receptors sure aren't expecting a basic amine in those spots). But many azasteroids do show biological activities, and I'd be quite surprised if these unknown compounds were pharmacologically inert. It's just that there's been no particular reason to make any of them yet. Chemical space is so huge, and our ability to explore it has been with us for such a relatively short time, that we just haven't gotten around to them yet.

Comments (8) + TrackBacks (0) | Category: The Scientific Literature


COMMENTS

1. Anonymous on March 16, 2010 9:11 AM writes...

Just about germane: years ago Dasent wrote a lovely book "Nonexistent compounds". It's a good way to learn some chemistry.

Permalink to Comment

2. NJBiologist on March 16, 2010 11:09 AM writes...

Y'know, steroids like that might make interesting tools for separating actions at traditional (DNA-binding) and non-traditional (GPCR/unknown) steroid receptors.

Permalink to Comment

3. JasonP on March 16, 2010 6:48 PM writes...

Well, you THINK you make new chemical species every day, but there is no telling what labs have made and are hiding across the world. :)

Permalink to Comment

4. Jose on March 16, 2010 6:58 PM writes...

Some of those amino-steroids might be in the running for the "Pole of Synthetic Inaccessibility" prize, I think.

Permalink to Comment

5. chemist on March 17, 2010 11:30 AM writes...

Caveat emptor: if you are relying on SciFinder to determine whether or not a structure (or reaction) is known you could be deluding yourself and others. I have held papers in my hand, drawn the structures and SciFinder does not find the compounds or source documents.

(You can sometimes have better success using CASOnLine.)

Permalink to Comment

6. MoD on March 17, 2010 7:55 PM writes...

Interesting post Derek. Way back (~18 yrs ago - OH MY!) when I was an undergraduate, I was making 16-azasteroids. Why? Because we had some nice methodology that allowed us to. Very interesting molecules, including aromatic pyrrole D-rings. My advisor had some connections, so we ended up sending them to the NCI or NIH for their screening collection. We never wrote a publication so you will not find them using any searches.

Permalink to Comment

7. Cartesian on March 18, 2010 5:38 AM writes...

May be with a new model for atom it will be better in order to discover some new things.

See article 3 part one and two here :

http://eternal-cartesian.blogspot.com/search?updated-min=2009-09-01T00%3A00%3A00-07%3A00&updated-max=2009-10-01T00%3A00%3A00-07%3A00&max-results=19

Permalink to Comment

8. KY on March 18, 2010 2:25 PM writes...

i believe that Gribble at Dartmouth had been funded to do exactly that a few years ago and came up with CDDO, the analogues which i had to synthesize.

Permalink to Comment

POST A COMMENT




Remember Me?



EMAIL THIS ENTRY TO A FRIEND

Email this entry to:

Your email address:

Message (optional):




RELATED ENTRIES
Academia and Industry, Suing Each Other
Let's Start Off the Meeting With An Ad, OK?
The Academic-Industrial Collaboration in Drug Discovery Panel: Today
Glass Structure, Atom by Atom
How the Andrulis Paper Got Published
AstraZeneca in Waltham
Fluorine NMR: Why Not?
AstraZeneca Layoffs and Closings